liefsmith. Of course there is a difference between MOA and the effect of the drug. But ,imo, the unique effect of regulation of inflammation at the beginning of the inflammatory cascade [pathways] through NF-kb is what gives Anatabine the EFFECT on so many different human afflictions.
Dr. Mullan in his presentation at investors day surly was quite positive about the effect of regulating through NF-kb. I do agree that all of the implications of this breakthrough discovery have not been yet investigated. Meaning there is going to be more than one MOA.
I am quite confident in my opinions expressed above. Time will tell. The Science will win in the end.
Of course, from a marketing standpoint a regulator is better than a "cure".
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.